An expression signature at diagnosis to estimate prostate cancer patients' overall survival

[1]  M. Terris,et al.  Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group. , 2013, Urology.

[2]  J. Lindberg,et al.  Genetic markers associated with early cancer‐specific mortality following prostatectomy , 2013, Cancer.

[3]  Jennifer R. Rider,et al.  Temporal trends in cause of death among Swedish and US men with prostate cancer. , 2012, Journal of the National Cancer Institute.

[4]  C. Galet,et al.  IGFBP-3 is a metastasis suppression gene in prostate cancer. , 2011, Cancer research.

[5]  G. Hankey,et al.  Associations of IGF1 and IGFBPs 1 and 3 with all-cause and cardiovascular mortality in older men: the Health In Men Study. , 2011, European journal of endocrinology.

[6]  Jane E. Visvader,et al.  Cells of origin in cancer , 2011, Nature.

[7]  J. Hansen,et al.  Testosterone, Hemostasis, and Cardiovascular Diseases in Men , 2011, Seminars in Thrombosis & Hemostasis.

[8]  C. Parker,et al.  Treating prostate cancer with radiotherapy , 2010, Nature Reviews Clinical Oncology.

[9]  Todd H. Stokes,et al.  k-Nearest neighbor models for microarray gene expression analysis and clinical outcome prediction , 2010, The Pharmacogenomics Journal.

[10]  P. Albertsen.  Treatment of localized prostate cancer: when is active surveillance appropriate? , 2010, Nature Reviews Clinical Oncology.

[11]  M. Terris,et al.  241 DO NOMOGRAMS DESIGNED TO PREDICT BIOCHEMICAL RECURRENCE (BCR) DO A BETTER JOB OF PREDICTING MORE DISTANT PROSTATE CANCER OUTCOMES THAN BCR?–A REPORT FROM THE SEARCH DATABASE GROUP , 2010 .

[12]  Dong-Myung Shin,et al.  Epiblast/Germ Line Hypothesis of Cancer Development Revisited: Lesson from the Presence of Oct-4+ Cells in Adult Tissues , 2010, Stem Cell Reviews and Reports.

[13]  M. Gerstein,et al.  Molecular sampling of prostate cancer: a dilemma for predicting disease progression , 2010, BMC Medical Genomics.

[14]  N. Mackman,et al.  The many faces of tissue factor , 2009, Journal of thrombosis and haemostasis : JTH.

[15]  N. Mackman,et al.  Role of Tissue Factor in Cancer , 2009 .

[16]  Pierre I Karakiewicz,et al.  An updated catalog of prostate cancer predictive tools , 2008, Cancer.

[17]  C. Logothetis,et al.  A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation , 2008, Oncogene.

[18]  C. D. Savci-Heijink,et al.  Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  G. Glinsky.  "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[21]  David W. Hosmer,et al.  Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .

[22]  H. Grönberg,et al.  MUC1 as a Putative Prognostic Marker for Prostate Cancer , 2008, Biomarker insights.

[23]  B. Garicochea,et al.  C8orf4/TC-1(Thyroid Cancer-1) Gene Expression in Thyroid Cancer and Goiter , 2006, ORL.

[24]  J. Cuzick,et al.  Long-term outcome among men with conservatively treated localised prostate cancer , 2006, British Journal of Cancer.

[25]  H. Clevers.  Stem cells, asymmetric division and cancer , 2005, Nature Genetics.

[26]  Robert C. Bast,et al.  Translational Crossroads for Biomarkers , 2005, Clinical Cancer Research.

[27]  D. Botstein,et al.  A DNA microarray survey of gene expression in normal human tissues , 2005, Genome Biology.

[28]  R. Tibshirani,et al.  Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Brown,et al.  Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[31]  M. Katoh,et al.  Expression and regulation of WNT5A and WNT5B in human cancer: up-regulation of WNT5A by TNFalpha in MKN45 cells and up-regulation of WNT5B by beta-estradiol in MCF-7 cells. , 2002, International journal of molecular medicine.

[32]  K. Pienta,et al.  The Current State of Hormonal Therapy for Prostate Cancer , 2002, CA: a cancer journal for clinicians.

[33]  Debashis Ghosh,et al.  alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. , 2002, JAMA.

[34]  C. N. Gundry,et al.  Real-time multiplex PCR assays. , 2001, Methods.

[35]  Christine Brun,et al.  In silico prediction of protein-protein interactions in human macrophages , 2001, BMC Research Notes.

[36]  P. V. Rao,et al.  Applied Survival Analysis: Regression Modeling of Time to Event Data , 2000 .

[37]  C. Larsson,et al.  Distinct deleted regions on chromosome segment 16q23–24 associated with metastases in prostate cancer , 1999, Genes, chromosomes & cancer.

[38]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Scardino,et al.  Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens. , 2011, The American journal of pathology.

[40]  G. Stamp,et al.  Androgen-dependent regulation of human MUC1 mucin expression. , 2002, Neoplasia.

[41]  B. Ljung,et al.  Fine needle aspiration biopsy for diagnosis and follow-up of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. , 1994, Scandinavian journal of urology and nephrology. Supplementum.

[42]  H. Klocker,et al.  Cytogenetics of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. , 1994, Scandinavian journal of urology and nephrology. Supplementum.

[43]  Brämer Gr.  International statistical classification of diseases and related health problems. Tenth revision. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[44]  G. Braemer.  International statistical classification of diseases and related health problems. Tenth revision. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.